Arcadia Biosciences (RKDA)
(Delayed Data from NSDQ)
$2.68 USD
-0.25 (-8.53%)
Updated Aug 2, 2024 03:49 PM ET
After-Market: $2.77 +0.09 (3.36%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.68 USD
-0.25 (-8.53%)
Updated Aug 2, 2024 03:49 PM ET
After-Market: $2.77 +0.09 (3.36%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Zacks News
3 Stocks to Watch in the Promising Agriculture - Products Industry
by Madhurima Das
The Agriculture - Products industry is set to gain from solid demand. Stocks like Bunge (BG), CalMaine Foods (CALM) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.
3 Stocks Worth a Look in the Thriving Agriculture - Products Industry
by Madhurima Das
With the Agriculture - Products industry set to gain from solid demand, stocks like Bunge Limited (BG), CalMaine Foods (CALM) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.
Arcadia Biosciences (RKDA) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 36.84% and 43.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Hecla Mining (HL) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Hecla Mining (HL) delivered earnings and revenue surprises of 50% and 12.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
GrowGeneration (GRWG) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
GrowGeneration (GRWG) delivered earnings and revenue surprises of 0% and 23.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
The Andersons (ANDE) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Andersons (ANDE) delivered earnings and revenue surprises of 51.52% and 34.22%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Bunge (BG) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Bunge (BG) delivered earnings and revenue surprises of 41.39% and 7.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Buy Stocks for October 24th
by Zacks Equity Research
BXRX, WOLF, GHRS, RKDA and BHR have been added to the Zacks Rank #1 (Strong Buy) List on October 24, 2022.
3 Stocks to Watch in the Promising Agriculture - Products Industry
by Madhurima Das
With the Agriculture - Products industry set to gain from solid demand, stocks like Bunge Limited (BG), CalMaine Foods (CALM) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.
Arcadia Biosciences (RKDA) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of -103.28% and -60.50%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
by Zacks Equity Research
Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
by Zacks Equity Research
Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Marijuana ETFs & Stocks Have More Room to Run
by Sanghamitra Saha
Marijuana stocks and ETFs are hot this year and can perform better in the coming days.
Why These Pharma ETFs Rallied on Thursday
by Sanghamitra Saha
A few pharma ETFs hit a one-month high on Feb 28. Why?
Arcadia Biosciences (RKDA) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 59.29% and 42.31%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.